查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1868261

生物可分解支架市場：依產品類型、材質、應用、最終用戶和通路分類－2025-2032年全球預測

Biodegradable Stents Market by Product Type, Material, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，可生物分解支架市場規模將達到 6.3932 億美元，複合年成長率為 5.19%。

關鍵市場統計數據
基準年 2024 4.2639億美元
預計年份：2025年 4.4859億美元
預測年份 2032 6.3932億美元
複合年成長率 (%) 5.19%

本書全面說明了可生物分解支架，涵蓋臨床進展、材料突破、法規環境和策略應用趨勢。

生物可分解支架代表介入性心臟病學和血管內治療領域的模式轉移，其發展動力源於在提供臨時機械支撐的同時，最大限度地減少長期異物殘留。該技術已從早期基於聚合物的支架所遭遇的重大臨床挫折，發展成為如今注重材料科學、可控吸收動力學和輸送性能的多元化平台方法。臨床醫生、器械工程師和醫院採購團隊現在不僅評估這些產品的急性支架性能，還評估其中長期血管癒合、影像相容性以及對再次介入治療的影響。

材料科學、成像技術和混合商業化模式的進步如何推動可生物分解支架的下一波臨床應用和技術差異化浪潮

生物可分解支架領域正經歷變革性的轉變，重塑臨床預期、生產重點和商業化策略。第一代生物可吸收血管支架的早期研究成果促使研究人員採用更有系統的方法進行研究設計、植入尺寸選擇和基於影像的隨訪，從而推動研發人員改進支架的幾何形狀、徑向強度和吸收時間。與這些技術進步同步，輔助成像技術（光學同調斷層掃描和高解析度血管內成像）也取得了長足發展，能夠對支架組織整合和血管癒合進行細緻入微的評估，這有助於提高監管申報的效率並增強臨床醫生的信心。

評估截至2025年實施的累積關稅如何影響可生物分解支架產業的採購經濟性、製造地和臨床應用時間表。

2025年生效或擴大的累積關稅措施對可生物分解支架生態系中相關人員的採購經濟性、供應鏈結構和採購決策產生了重大影響。對於依賴跨境供應關鍵原料（例如高純度鎂合金原料和特殊聚合物）的製造商而言，某些投入品和成品醫療設備的關稅推高了到岸成本，同時也加劇了醫院採購委員會對價格的敏感度。為因應這項挑戰，製造商正在加速實施雙重籌資策略，地域多角化，並明確長期供應契約，以降低自身受貿易政策波動的影響。

深入的細分分析重點在於臨床定位、材料權衡和市場上市差異化因素，這些因素影響可生物分解支架技術的應用。

細分市場分析揭示了不同的臨床、技術和商業性動態，這些動態指南著產品、材料、應用、終端用戶和分銷等各個維度的策略優先排序。依產品類型分類，競爭格局涵蓋可生物分解聚合物塗層金屬支架和生物可吸收血管支架，後者可進一步細分為球囊擴張型和自擴張式裝置。這些差異至關重要，因為輸送性、徑向強度和部署精確度會影響臨床醫生的選擇和手術流程。依材料分類，平台主要集中在鎂合金或聚左旋乳酸）基材；聚左旋乳酸的變體，例如複合PLA和PLLA，會改變分解特性和影像特徵，從而影響後續觀察通訊協定和患者選擇。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 聚合物基生物可吸收血管支架在介入性心臟病學手術的應用日益廣泛
  • 將先進的藥物釋放型技術整合到可生物分解支架中，以標靶預防血管再阻塞
  • 鎂合金和生物可吸收金屬支架的出現提高了徑向強度和安全性
  • 臨床試驗結果表明，在低風險患者族群中，生物可吸收支架和耐用金屬支架的療效相當。
  • 監管方面的進步和核准的加快，正在加速下一代可生物分解支架進入歐洲和亞洲市場。
  • 醫療設備製造商與研究機構合作，開發出一種具有客製化分解特性的多藥洗脫生物可吸收血管支架。
  • 人們越來越關注成本效益高的製造方法和永續的滅菌技術，以實現可生物分解支架的大規模生產。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按產品類型分類的可生物分解支架市場

  • 可生物分解聚合物塗層金屬支架
  • 生物可吸收血管支架
    • 球囊擴張型
    • 自膨脹

9. 按材質分類的可生物分解支架市場

  • 鎂合金
  • 聚左旋乳酸
    • 複合PLA
    • PLLA

第10章 按應用分類的可生物分解支架市場

  • 冠狀動脈疾病
    • 急性心肌梗塞
    • 慢性完全閉塞
  • 周邊動脈疾病

第11章 按最終用戶分類的可生物分解支架市場

  • 門診手術中心
  • 醫院
    • 心臟中心
    • 循環系統

第12章 按分銷通路分類的可生物分解支架市場

  • 直銷
    • 內部銷售團隊
    • OEM
  • 經銷商

第13章 各地區可生物分解支架市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 依組別分類的生物可分解支架市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國可生物分解支架市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Terumo Corporation
    • Meril Life Sciences Private Limited
    • Sahajanand Medical Technologies Private Limited
    • Elixir Medical Corporation
    • REVA Medical, Inc.
    • Xeltis AG
    • Xtent SA
Product Code: MRR-4D00F1312C7E

The Biodegradable Stents Market is projected to grow by USD 639.32 million at a CAGR of 5.19% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 426.39 million
Estimated Year [2025] USD 448.59 million
Forecast Year [2032] USD 639.32 million
CAGR (%) 5.19%

An authoritative introduction to biodegradable stents that frames clinical evolution, material breakthroughs, regulatory context, and strategic adoption dynamics

Biodegradable stents represent a paradigm shift in interventional cardiology and endovascular therapy, driven by the pursuit of transient mechanical support that minimizes long-term foreign-body presence. The technology arc has moved from early polymer-based scaffolds with high-profile clinical setbacks toward a diversified set of platform approaches that emphasize material science, controlled resorption kinetics, and deliverability. Clinicians, device engineers, and hospital procurement teams now evaluate these products not only on acute scaffold performance but on mid- and long-term vessel healing, imaging compatibility, and implications for repeat interventions.

Simultaneously, regulatory pathways and post-market surveillance frameworks have matured to incorporate device-specific endpoints such as late lumen loss, scaffold thrombosis, and vessel remodeling. This evolution has encouraged iterative improvements in magnesium alloy formulations and refinements to poly-L-lactic acid constructs, while also stimulating innovations around polymer coatings for metallic stents that aim to combine the immediate mechanical reliability of metal with a bioresorbable interface. As adoption considerations become more nuanced, strategic questions center on clinical positioning, comparative evidence generation, and supply chain resilience, all of which will determine how biodegradable platforms integrate into standard care algorithms.

How material science, imaging advances, and hybrid commercialization models are driving the next wave of clinical adoption and technology differentiation in biodegradable stents

The landscape for biodegradable stents has experienced transformative shifts that are reshaping clinical expectations, manufacturing priorities, and commercialization strategies. Early lessons from first-generation bioresorbable vascular scaffolds catalyzed a more disciplined approach to trial design, implant sizing, and imaging-driven follow-up, prompting developers to iterate on strut geometry, scaffold radial strength, and resorption timelines. These technical refinements are accompanied by advances in adjunctive imaging-optical coherence tomography and high-resolution intravascular imaging-that enable granular assessment of scaffold integration and vessel healing, thereby informing both regulatory submissions and clinician confidence.

Concurrently, materials innovation has broadened the available toolkit: magnesium alloy platforms emphasize more rapid, controlled resorption with favorable mechanical profiles, while poly-L-lactic acid-based solutions focus on prolonged structural support with tunable degradation. The lines between permanent metal stents and bioresorbable concepts are blurring through hybrid approaches such as biodegradable polymer coatings on metallic scaffolds, which seek to balance long-term patency with reduced chronic inflammation. Market participants are also recalibrating commercial models, with suppliers prioritizing robust clinical evidence, tailored training programs for operators, and service-oriented post-market follow-up to accelerate adoption within centers of excellence and cardiology networks.

Assessment of how 2025 cumulative tariff actions have reshaped procurement economics, manufacturing footprints, and clinical adoption timelines in the biodegradable stent sector

Cumulative tariff measures enacted or expanded in 2025 exert a tangible influence on procurement economics, supply-chain structuring, and sourcing decisions for stakeholders in the biodegradable stent ecosystem. Tariffs on specific inputs and finished medical devices raise landed costs for manufacturers that rely on cross-border supply of critical raw materials such as high-purity magnesium alloy feedstock and specialty polymers, while also increasing the price sensitivity of hospital purchasing committees. In response, manufacturers have accelerated dual-sourcing strategies, regionalized production footprints, and clarified long-term supplier agreements to mitigate exposure to further trade policy volatility.

The tariff environment has also prompted a chain reaction that affects clinical adoption timing: health systems under cost pressure may delay elective procedures or prioritize devices with clearer near-term budgetary benefits, which in turn influences the cadence of evidence generation and real-world data collection. Some firms have adopted localized assembly and final testing to reduce tariff burdens on finished goods, thereby shifting capital investment and talent requirements toward regions with favorable trade treatments. Looking ahead, the cumulative effect of tariffs is better characterized as a driver of operational adaptation-reshaping pricing strategies, inventory policies, and partnership models-rather than a deterministic barrier to technological advancement.

In-depth segmentation insights that illuminate clinical positioning, material trade-offs, and go-to-market differentiators shaping adoption of biodegradable stent technologies

Segmentation analysis reveals distinct clinical, technical, and commercial dynamics across product, material, application, end-user, and distribution dimensions that guide strategic prioritization. Based on Product Type, the competitive set spans Biodegradable Polymer Coated Metallic Stents and Bioresorbable Vascular Scaffolds, with the latter further differentiated into Balloon Expandable and Self Expanding devices; these distinctions matter because deliverability, radial strength, and deployment precision influence operator preference and procedural workflows. Based on Material, platforms gravitate toward Magnesium Alloy or Poly-L-Lactic Acid substrates, where Poly-L-Lactic Acid variations such as Composite PLA and PLLA alter degradation profiles and imaging signatures, affecting follow-up protocols and patient selection.

Based on Application, clinical targeting bifurcates between Coronary Artery Disease and Peripheral Artery Disease, with Coronary Artery Disease use later stratified into Acute Myocardial Infarction and Chronic Total Occlusion contexts that present different lesion morphologies and risk tolerances. Based on End User, adoption pathways differ between Ambulatory Surgery Centers and Hospitals, and within hospitals the dynamics vary between Cardiac Centers and Cardiology Departments because high-volume, specialized cardiac centers often accelerate procedural innovations. Finally, based on Distribution Channel, commercial approaches split across Direct Sales and Distributors, and direct-sales models that deploy In House Sales Teams or Original Equipment Manufacturer partnerships change customer engagement intensity and post-sale service expectations. Understanding these segmentation layers clarifies where clinical evidence, training, and supply continuity will most effectively translate into adoption and commercial success.

Comparative regional intelligence that decodes regulatory nuances, clinical adoption patterns, and manufacturing influences across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional performance and strategic priorities for biodegradable stents differ markedly across the Americas, Europe, Middle East & Africa, and Asia-Pacific, driven by regulatory frameworks, clinical practices, and manufacturing capacity. In the Americas, advanced interventional cardiology networks and a concentrated set of high-volume cardiac centers make the region a proving ground for devices that demonstrate clear procedural advantages and compatibility with existing imaging workflows; payer considerations and hospital procurement cycles inform rollout strategies and evidence generation plans. In Europe, Middle East & Africa, fragmented regulatory landscapes and varied reimbursement policies create a mosaic of adoption speeds, where early adopters in advanced cardiac centers coexist with markets that require more extensive health-economic demonstration to convince payers.

The Asia-Pacific region combines rapidly expanding procedural volumes with strong manufacturing ecosystems and an increasing appetite for locally produced solutions. Local clinical investigators and regional regulators are playing a more visible role in shaping device design and post-market evidence requirements. Across all regions, differences in operator training pathways, hospital procurement practices, and supply chain resiliency underscore the need for nuanced regional commercialization roadmaps that align clinical data campaigns with local regulatory expectations and distribution capabilities. Harmonizing global clinical evidence strategies with region-specific value propositions will be decisive for organizations seeking multi-regional scale.

Strategic company-level analysis that highlights innovation pathways, partnership models, and commercial competencies driving competitive advantage in biodegradable stents

Company-level dynamics in the biodegradable stent domain are characterized by a mix of incumbent cardiovascular device manufacturers, specialized medtech innovators, and vertically integrated suppliers that combine materials science with regulatory expertise. Leading organizations consistently invest in iterative product development informed by operator feedback, controlled clinical studies with robust imaging endpoints, and post-market surveillance programs that address long-term vessel healing. Strategic partnerships between material suppliers and device OEMs are increasingly common, enabling faster optimization of alloy compositions, polymer blends, and coating chemistries that refine resorption timing and mechanical performance.

Smaller, more agile entrants focus on niche indications or platform enhancements-such as lower-profile delivery systems, hybrid scaffolds, or adjunctive imaging software-targeting centers of excellence where adoption velocity is highest. Across the competitive landscape, successful companies exhibit disciplined regulatory strategies, clear training and proctoring pathways for clinicians, and pragmatic pricing models that consider hospital capital constraints and procedural reimbursement realities. As supply-chain pressures and tariff-related cost dynamics continue to influence unit economics, firms with diversified manufacturing footprints and flexible distribution agreements will maintain tactical advantages in sustaining commercial momentum.

Actionable, cross-functional recommendations for companies to accelerate adoption, secure supply chains, and align clinical evidence with commercial strategies in biodegradable stents

Industry leaders should align clinical, manufacturing, and commercial strategies to accelerate safe adoption while mitigating operational risk. Prioritize investment in rigorous clinical evidence programs that leverage high-resolution imaging and real-world registries to demonstrate scaffold integration, late lumen behavior, and comparative outcomes in clearly defined patient cohorts; such data builds clinician trust and supports differentiated labeling. Concurrently, de-risk supply chains by diversifying raw-material sources for magnesium alloys and specialty polymers, exploring localized assembly options, and instituting strategic inventory buffers to guard against trade-policy disruptions or component shortages.

Commercially, tailor engagement models to end-user profiles: provide hands-on training and proctoring for cardiac centers that drive early adoption while offering simplified procurement pathways and technical support for ambulatory surgery centers. Emphasize hybrid product families-biodegradable polymer coatings on metallic platforms or hybrid scaffolds-that address the clinical demand for predictable acute performance with reduced long-term device footprint. Finally, adopt value-based pricing discussions with payers by correlating device attributes with procedural efficiency, reduced long-term complications, and potential downstream cost offsets, thereby aligning reimbursement conversations with clinical and economic evidence.

A transparent, multi-modal research methodology combining clinical evidence synthesis, regulatory review, expert interviews, and supply-chain analysis to underpin strategic insights

The research employed a multi-modal methodology that integrates peer-reviewed clinical literature, regulatory guidance documents, device labeling, and interviews with clinicians, supply-chain specialists, and industry executives to ensure balanced, evidence-driven conclusions. Clinical evidence synthesis prioritized randomized and prospective observational studies with imaging-based endpoints, while complementary analyses incorporated expert surveys and structured interviews to capture operator experience, adoption barriers, and training needs. Regulatory review considered regional pathways and post-market surveillance expectations, with attention to device-specific requirements for resorbable materials and scaffold-related endpoints.

Supply-chain and tariff analyses combined customs and trade policy reviews with interviews of procurement managers and component suppliers to map exposure to input-cost volatility and logistical constraints. Commercial modeling focused on segmentation-driven adoption scenarios without projecting aggregate market sizes, using case-study approaches to illustrate how product design, distribution strategy, and regional regulatory alignment influence commercial outcomes. Throughout, methodological triangulation-cross-verifying insights from clinical, regulatory, and commercial sources-was used to increase the robustness of findings and to highlight areas where targeted primary research would most effectively close evidence gaps.

A concise conclusion that synthesizes technology readiness, clinical adoption pathways, and strategic priorities for responsible expansion of biodegradable stent use

Biodegradable stents now stand at an inflection point where material advances, pragmatic hybrid designs, and more rigorous clinical evaluation can translate the promise of resorbable technology into durable clinical use. The field has learned from early generational challenges and has responded with technologies that better balance acute mechanical needs with controlled degradation, enhanced imaging compatibility, and refined deployment systems. Adoption will be uneven across clinical contexts and geographies, but the cumulative progress in device performance, clinician training, and regulatory clarity provides a realistic pathway for broader integration into interventional cardiology and peripheral interventions.

Successful stakeholders will be those who combine strong clinical evidence strategies with resilient manufacturing and distribution approaches, mindful of trade-policy and reimbursement dynamics. By focusing on clear clinical differentiation, localized commercial execution, and systematic post-market learnings, the industry can responsibly expand device availability while preserving patient safety and procedural effectiveness. The trajectory for biodegradable stents is not a simple replacement of permanent implants but a more nuanced expansion of therapeutic options that can be tailored to patient risk profiles and lesion characteristics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of polymer-based bioresorbable vascular scaffolds in interventional cardiology procedures
  • 5.2. Integration of advanced drug-elution technologies in biodegradable stents for targeted restenosis prevention
  • 5.3. Emergence of magnesium alloy and bioresorbable metal scaffolds to enhance radial strength and safety
  • 5.4. Clinical trial outcomes demonstrating comparable efficacy of bioresorbable stents versus durable metallic scaffolds in low-risk patient cohorts
  • 5.5. Regulatory advancements and fast-track approvals accelerating market entry of next-generation biodegradable stents in Europe and Asia
  • 5.6. Collaboration between device manufacturers and research institutions to develop multi-drug eluting bioresorbable vascular scaffolds with tailored degradation profiles
  • 5.7. Increased focus on cost-effective manufacturing processes and sustainable sterilization techniques for large-scale production of biodegradable stents

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biodegradable Stents Market, by Product Type

  • 8.1. Biodegradable Polymer Coated Metallic Stents
  • 8.2. Bioresorbable Vascular Scaffolds
    • 8.2.1. Balloon Expandable
    • 8.2.2. Self Expanding

9. Biodegradable Stents Market, by Material

  • 9.1. Magnesium Alloy
  • 9.2. Poly-L-Lactic Acid
    • 9.2.1. Composite Pla
    • 9.2.2. Plla

10. Biodegradable Stents Market, by Application

  • 10.1. Coronary Artery Disease
    • 10.1.1. Acute Myocardial Infarction
    • 10.1.2. Chronic Total Occlusion
  • 10.2. Peripheral Artery Disease

11. Biodegradable Stents Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
    • 11.2.1. Cardiac Centers
    • 11.2.2. Cardiology Departments

12. Biodegradable Stents Market, by Distribution Channel

  • 12.1. Direct Sales
    • 12.1.1. In House Sales Team
    • 12.1.2. Original Equipment Manufacturer
  • 12.2. Distributors

13. Biodegradable Stents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biodegradable Stents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biodegradable Stents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Biotronik SE & Co. KG
    • 16.3.3. Boston Scientific Corporation
    • 16.3.4. Terumo Corporation
    • 16.3.5. Meril Life Sciences Private Limited
    • 16.3.6. Sahajanand Medical Technologies Private Limited
    • 16.3.7. Elixir Medical Corporation
    • 16.3.8. REVA Medical, Inc.
    • 16.3.9. Xeltis AG
    • 16.3.10. Xtent S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BIODEGRADABLE STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BIODEGRADABLE STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIODEGRADABLE STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIODEGRADABLE POLYMER COATED METALLIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIODEGRADABLE POLYMER COATED METALLIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIODEGRADABLE POLYMER COATED METALLIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIODEGRADABLE POLYMER COATED METALLIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIODEGRADABLE POLYMER COATED METALLIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIODEGRADABLE POLYMER COATED METALLIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY SELF EXPANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MAGNESIUM ALLOY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MAGNESIUM ALLOY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MAGNESIUM ALLOY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MAGNESIUM ALLOY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MAGNESIUM ALLOY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY MAGNESIUM ALLOY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY COMPOSITE PLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY COMPOSITE PLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY COMPOSITE PLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY COMPOSITE PLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY COMPOSITE PLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY COMPOSITE PLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PLLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PLLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PLLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PLLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PLLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PLLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIOLOGY DEPARTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIOLOGY DEPARTMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIOLOGY DEPARTMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIOLOGY DEPARTMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIOLOGY DEPARTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY CARDIOLOGY DEPARTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY IN HOUSE SALES TEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY IN HOUSE SALES TEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY IN HOUSE SALES TEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY IN HOUSE SALES TEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY IN HOUSE SALES TEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY IN HOUSE SALES TEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIODEGRADABLE STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA BIODEGRADABLE STENTS MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, 2025-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC BIODEGRADABLE STENTS MARKET